about
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-bas...
Read More
4.18
-0.08
(-1.88%)
2.8M
XNAS Volume
XNAS 15 Jul, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Altimmune Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..